Fig. 2.
Steady-state plasma insulin (SSPI) during euglycemic clamp (A) and clamp-derived insulin clearance (B). Data are presented as means ± SE. *Significantly different from baseline (P < 0.05), ^significantly different from P after the 12-wk intervention period (P < 0.05).